rs41457746

Positions:

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_000517.6(HBA2):​c.96-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 9)
Exomes 𝑓: 0.000041 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

HBA2
NM_000517.6 splice_acceptor, intron

Scores

2
2
3
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 8.62
Variant links:
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 3.4, offset of 28, new splice context is: tgtccttccccaccaccaAGacc. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PP5
Variant 16-173123-A-G is Pathogenic according to our data. Variant chr16-173123-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 15679.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-173123-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HBA2NM_000517.6 linkuse as main transcriptc.96-2A>G splice_acceptor_variant, intron_variant ENST00000251595.11 NP_000508.1 P69905D1MGQ2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HBA2ENST00000251595.11 linkuse as main transcriptc.96-2A>G splice_acceptor_variant, intron_variant 1 NM_000517.6 ENSP00000251595.6 P69905
HBA2ENST00000484216.1 linkuse as main transcriptc.63-2A>G splice_acceptor_variant, intron_variant 1 ENSP00000495899.1 A0A2R8Y7C0
HBA2ENST00000482565.1 linkuse as main transcriptn.230A>G non_coding_transcript_exon_variant 1/21
HBA2ENST00000397806.1 linkuse as main transcriptc.-1-2A>G splice_acceptor_variant, intron_variant 2 ENSP00000380908.1 G3V1N2

Frequencies

GnomAD3 genomes
AF:
0.0000332
AC:
2
AN:
60196
Hom.:
0
Cov.:
9
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000595
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000409
AC:
23
AN:
562962
Hom.:
0
Cov.:
7
AF XY:
0.0000539
AC XY:
16
AN XY:
297030
show subpopulations
Gnomad4 AFR exome
AF:
0.0000700
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000573
Gnomad4 OTH exome
AF:
0.0000670
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000332
AC:
2
AN:
60196
Hom.:
0
Cov.:
9
AF XY:
0.00
AC XY:
0
AN XY:
27086
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000595
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Pathogenic, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Pathogenic, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesSep 28, 2023The IVS-I-116 variant (HBA2: c.96-2A>G, HbVar ID: 1066, rs41457746) is reported in the literature in multiple individuals affected with alpha (+) thalassemia in the heterozygous state (see HbVar and references therein, Bayat 2013). This variant was observed in trans with the alpha 3.7 deletion in an individual with alpha thalassemia with Hb H inclusion bodies (Harteveld 2003). Additionally, this variant was detected in a fetus with Hb H disease in trans with the Southeast Asian deletion (--SEA) (He 2018). This variant is also reported in ClinVar (Variation ID: 15679). This variant is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant disrupts the canonical splice acceptor site of intron one, which is likely to negatively impact gene function. Analyses of the variant transcript show intron one is retained leading to a premature stop codon and post-transcriptional instability (Harteveld 1996). Based on available information, this variant is considered to be pathogenic. References: Link to HbVar: https://globin.bx.psu.edu/hbvar/menu.html Bayat N et al. Novel mutations responsible for alpha-thalassemia in Iranian families. Hemoglobin. 2013;37(2):148-59. PMID: 23402770. Harteveld CL et al. An IVS1-116 (A-->G) acceptor splice site mutation in the alpha 2 globin gene causing alpha + thalassaemia in two Dutch families. Br J Haematol. 1996 Dec;95(3):461-6. PMID: 8943885. Harteveld CL et al. The Dutch IVS-I-116 (A --> G) (alpha2) thalassemia mutation induces Hb H inclusion bodies when found in combination with the -alpha3.7 deletion defect. Hemoglobin. 2003 Feb;27(1):49-51. PMID: 12603095. He XH et al. First Report of a Case with Nondeletional Hb H Disease Caused by IVS-I-116 (A>G) of the alpha2-Globin Gene. Hemoglobin. 2018 Sep-Nov;42(5-6):344-346. PMID: 30676123. -
Pathogenic, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
alpha Thalassemia;C0700299:Heinz body anemia;C3161174:Hemoglobin H disease;C4693823:Erythrocytosis, familial, 7 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsNov 05, 2021- -
Alpha-thalassemia, Dutch type Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 01, 2003- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.60
D
BayesDel_noAF
Benign
-0.14
CADD
Pathogenic
34
DANN
Benign
0.96
Eigen
Pathogenic
0.87
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.90
D
GERP RS
4.2

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.78
SpliceAI score (max)
1.0
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.68
Position offset: 30
DS_AL_spliceai
1.0
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41457746; hg19: chr16-223122; API